HENDERSON, Nev.--(BUSINESS WIRE)-Emergency Filtration Products Inc. (EFP) (OTCBB: EMFP) announces that it will commence testing its licensed nanotechnology-enhanced 2H filter media in conjunction with the U.S. Air Force in mid-August 2004. This proprietary enhancement encompasses the integration of filter media with various types of nanotechnology solutions for the detection of, and protection from, biological, chemical, radiological and explosive agents.

The U.S. Air Force tests, which are expected to validate some previous testing performed by EFP, will measure the nano-enhanced filter media's efficacy in combating several identified biological contaminants, including: Staphylococcus aureas, Bacillus cereus spores, Klebsiella pneumonia, MS2, Aspergillus niger spores and Trichophyton. Initial tests performed at Nelson Laboratories indicated the ability to arrest and eradicate the rapid growth of endospores. The Nelson Laboratories tests were conducted with bacillus thuringiensis -- an endospore that is genotypically and phenotypically similar to bacillus anthracis, more commonly known as anthrax.

The testing will be conducted at the U.S. Army's Edgewood Chemical Biological Center facilities in Edgewood, Md. under the direction of the U.S. Army Research, Development and Engineering Command (RDECOM), which was formerly known as the U.S. Army Soldier and Biological Chemical Command (SBCCOM). The tests are expected to take no longer than two weeks.

For the past 17 months, EFP has been working in conjunction with RDECOM to test its nano-enhanced 2H filter technology in order to accelerate the commercial development of a number of filter technology applications and allow for rapid procurement by the U.S. Department of Defense. Every branch of the U.S. military has now chosen EFP's filter media for testing. Additional protocols and specifications will be issued by various branches of the military and are expected to quickly follow the Air Force tests. EFP expects that each branch of the military will test EFP's filter media against microorganisms that relate to their respective concerns.

RDECOM has been examining how to apply the company's filter technology to a large number of potential applications, including, but not limited to: biohazard masks, transportation (aircraft, tanks, armored personnel carriers) and buildings (military, industrial, office and residential). The program has conducted a number of cost and user needs analyses, economic analyses and technical viability studies of EFP's proprietary 2H filter technology. Over 1,000 potential applications of EFP's filter technology have been identified by RDECOM.

About RDECOM:
http://www.rdecom.army.mil/index.html

MISSION -- Get the right integrated technologies into the hands of warfighters quicker.
VISION -- To be recognized as the preeminent world leader in research, development and engineering of systems, whose hallmark is transitioning the right technology in the shortest time to our soldiers.
INTENT -- The Commanding General of the U.S. Army Materiel Command (AMC) established the U.S. Army Research, Development & Engineering Command (RDECOM), as a new major subordinate command within AMC. This new command will restructure core in-house capabilities now so we can fully exploit the enormous potential that resides in research activities around the world. RDECOM will respond rapidly by integrating, maturing and demonstrating emerging technologies to field the right equipment, in the shortest time, for our soldiers.

About ECBC:
http://www.ecbc.army.mil/

ECBC is the nation's principal research and development center for chemical and biological defense. Tracing its roots back to 1917, ECBC leverages more than 85 years of experience with live agent to develop and enhance defense systems.
ECBC seeks opportunities to develop partnerships with industry, academia and state and local governments to continue achieving major technological advances for national defense, civilian protection and industrial competitiveness. Complementing these efforts, the Center offers several unique facilities that provide full life-cycle support to chemical and biological protection, detection and monitoring capabilities.

About Emergency Filtration Products Inc.:
www.emergencyfiltration.com

EFP is an air filtration products manufacturer whose patented 2H Technology(TM) filter system has produced filtration efficiencies of "greater than 99.99%" at a particulate size of 0.027 microns. Its initial products were developed for the medical market: the Vapor Isolation Valve(TM) and RespAide(TM) CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases; and the 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received FDA approval. The company also markets an Automated External Defibrillator Prep Kit featuring RespAide and the NanoMask(R), a nanotechnology enhanced environmental mask. In addition to filtration products, the company supplies Superstat(R), a modified hemostatic collagen, to the U.S. military for surgery and extreme wound care.
Contacts

Emergency Filtration Products Inc.
702-558-5164
Fax: 702-567-1893
contactus@emergencyfiltration.com
www.emergencyfiltration.com
or
WPH Consultants Ltd. (Investor Relations)
Philippe Niemetz, 800-477-7570 or 212-344-6464
Fax: 212-618-1276
philippe.niemetz@wphconsultants.com